RE:Where is Patient #4 6month results?Probably safe to assume #4 experienced recurrence or the stock would be $1USD, and we would of heard about it already. Therefore unless some of the remaining patients have no recurrence there won't be a Ph2 unless another entity is willing to sponsor us. IMO maybe best to go after one of the other indications in a Ph1. Something where more definitive results can be demonstrated. Don't misunderstand me. I think the results to date for this Ph1 have been stellar, certainly much better than removing some ones bladder. Tld1433 2 or 3 times a year seems preferable to eventual bladder removal. It's just that so far the market thinks otherwise given the 22 cent share price.
Mickey2 wrote: Roger sleeping at the switch?